|
| 1 | Lignocaine with Adrenaline - Inj.- Lignocaine OR Lidocaine HCL 20mg + Adrenaline or Epinephrine 5 mcg per ml 30 ml Inj |
| 2 | Oral Rehydration SaltPowder 20.5 gm Sachet- ORS WHO Formula- ORS Powder 20.5 gm as per WHO formule contains g/I : Sodium Chloride IP 2.60 gm, Potasium Chloride IP 1.50 gm, Sodium nitrate IP 2.90 gm , Anhydrous Dextrose IP 13.50 gm The total osmolar concentrationof the solution in terms of mosmol per litre is 245 |
| 3 | Inj. Gentamycin 40 mg/ml - 2 ml amp/ViaI |
| 4 | Amlodepin Tab. 5 mg |
| 5 | Tab. Atenolol 50 mg |
| 6 | Tab. Telmisartan 40 mg |
| 7 | Tab. Chlorthalidone 12.5 mg |
| 8 | Atorvastaiin Tab 10 mg |
| 9 | Metformin Tab 500 mg |
| 10 | Glimiperide1mg Tab |
| 11 | Tab Glimepiride 2 mg |
| 12 | Acetyl salicylic acid Tab. 75 mg I.P |
| 13 | Clopidogrel Tab 75 mg |
| 14 | Anti Rabies vaccine Tissue culiure 2.5 I U per vial or amporPurified vero cell Rabies vaccine 2.5 IU per Vial or amp orpurified chick embryo vaccine 2.5 IU per vial or amp & Sterile water for injection as diluents, Label should Indicate for ID/ IM use Ampoule/ Vial of 1 ml |
| 15 | HydrocortisoneSodium Succitate Inj 100mg |
| 16 | Dexamethasone Inj. 4 mg/ml |
| 17 | Sodium Chloride - Normal Saline 0.9% Inj 500 ml - IVsodium chioride |Normal saline 0.9 %isotonic (equivalentto Na+ 154 mmol/L,CI-154 mmol/L).w/v AFFS/BFS/FFS Technology |
| 18 | Ringer Lactate Inj. I.V 500 ml- I. V. Ringer\"s Lactate(Sodium lactate, compound solution ) Each 1ooml to contain: lactic Acid 0.24 ml., Sod.Chl. 0.6 gm, Potassium Chloride 0.04 gm, Calcium Chloride 0.027 gm. Water for injection Q.S. carculated osmolarity -280 mos/L(approx) Sodium 131, Potassium 5, Calcium 2, Bicarbonate (as Lactate) 29, Chloride 111.AFFS/BFS/FFS Technology |
| 19 | Ironfolic acid Tab (60 mg of elemental iron + folic Acid I P 500 mcg) |
| 20 | IFA Syrup wilh Auto Dispenser 50 ml |
| 21 | Syrup Calcuim with Phosphate200 ml Each 5 ml contains: Vitamin D3 (choIecaIciferoI)I.P. 200 IU, vitamin B12 (Cynocobalamin) I.P.2.5 mcg, Calcium phosphace 82 mg |
| 22 | Inj. Pilocarpine Nitrate0.5% ( for Intracameral use preservative free) |
| 23 | Ciprofloxacin + Dexamethasone Eye Drops 5 ml- Ciprofloxacin 0.3% w/v Dexamethasone 0.1% w/v E/D. (5 mL Vial) |
| 24 | Inj. Hydroxy Propyl Methyl Cellulose USP 2% in Sterile Isonic base PFS - Prefilled preferably in glass syringes in double pouch packing . Hydroxy Propyl Methyl Cellulose USP 2% w/v, in sterile isonic base 2mI PFS For intraocular use |
| 25 | Povidone Iodine Drops 5 ml - Povidone Iodine 5% w/v Eye Drops, Solution Each single dose container provides 25 mg of lodinated Povidone in 0.5 ml of solution. One ml of solution contains 50 mg lodinated Povidone |
| 26 | Homatropine Drops 5 ml - Isoptohomatropine Methylbromide2% Drop - 5 ml |
| 27 | Tropicamide + Phenyleprin HCL Eye Drop 5 ml - Tropicamide 0.8% w/ v & Phenylephrine Hydrocloride 5% w/v |
| 28 | Moxifloxacin Eye Drop 0.5%, 5 ml - Moxifloxacin Eye Drop 0.5 % 5 ml |
| 29 | Inj. Trypan Blue 0.06%, 5 ml - (Trypan Blue Ophthalmic Solution 0.069% w/v) 0.6 mg/mIEach mlcontains: 0.6 mg trypan blue; |
| 30 | Hyluronidase Inj. 2 ml - Inj. Hyaluronidase (2 ml Vial, each Vial contain 1500 International Units of Hyluronidase) |
| 31 | Moxifloxacine + Prednisolone Acetate Eye Drop 5mI - Moxifloxacin0.5% with prednisolone 1% Eye Drop 5ml Vial(Moxifloxacin Hydrocloride equivalent to Moxifloxacin0.5% w/v. prednisoloneacetate - usp 1%w/v, Benzalkonium Chloride solution { as preservative) -IP 0.02% w/vsterile aqueous base |
| 32 | Intra Ocular LensesEach( +17.00 Diopter power to +23.00 Diopter power)( 0.5 Diopter increments) (Appasamy/Eye Care/Optima) |
| 33 | Bupivacaine Hydrochloride Inj 0.5% 10 ml Vial - Inj Bupivacaine Hydrochloride 50 mg/10ml |
| 34 | Ciprofloxacin Eye Ointment 5 gm - Ciprofloxacin Eye ointment (Ciprofloxacin Hydrocloride equivalent to 3 mg/g, Ciprofloxacin in an anhydrous Ophth Oint base ) |
| 35 | Disposable Needle26GEach(½ \" Inch.) - Disposable Sterile Needle no. 26 1\" to 1.5 \" Disp.Sterilised Needles In Blister Pack / Riboon Pack Siliconised Sizes 26 G with CE certification (½ \" Inch.) |
| 36 | Nonabsorable microsuture monofilament nylonSize 10-0Box of 12 Foils - Sutures (10-0) ( Box of 12 Each) SU - NA 050 { Non Absorble microsuture monifilament Nylone CSU 3/8 circle microspatulated (Double Needle) 6mm, Size 10/0 Length 38 cm} |
| 37 | Proparacaine Eye Drops5 ml - Proparacain 0.5 % E/D (Proparacain Hydrochloride 0.5 % Eye drop |
| 38 | Tunnel Blade (Appasamy/Optho - micro/Auro Lab) 1) 1 mm MVR blade with handle is required for the side port incision. It should be bibeveled, spear shape 20 gauge, ophthalmic micro surgical full handled knife. 2) 3.2 mm Ker tome or slit knife with handle is required for the entry in to anterior chamber, It should be pointed tip angled Bevel up, ophthalmic microscope full handled knife. 3) 2.6mm Crescent Blade is required for dissecting tunnel. It should be angled bevel up, ophthalmic microsurgical full handled knife. All blades should be etiosterilized and disposable. All handles should be autoclavable |
| 39 | Tab Levosalbutamol 2 mg |
| 40 | Inj. Adrenaline Injection (1mg)+ Sodium Metabisulphite (0.1%w/v) |
| 41 | Transpore - Skin Barrier Micro Pour Surgical Tape Transperant 1 ½ Inch. |
| 42 | Polydrapes (Eye) Disposable - Material : sms 35 gsm water repellent.Size : 60x60cm,70x70cm,100x70cm,40x50cm,25x20cm, Adhesive area : 7x9 cmDrain pouch(poly): 1nos Eye lid holder : 4 nossterilized by ETO |
| 43 | E/D Flurbiprofen (0.03% W/V ) - E/D Flurbiprofen (0.03% W/V ) |
| 44 | Chloramphenicol, Polymyxin-B Sulphate & Dexamethasone Sodium Phosphate Eye Ointment - Polymyxin-B Sulphate BP – 10000 UnitsChloramphenicol IP- 10 mgDexamethasone Sodium Phosphate IP- 1 mgSterile Base – q.s. |
| 45 | Thread No 40 |
| 46 | Tab Enalpril 5 mg |
| 47 | Levosalbutamol Syrup 1 mg /5 ml 100 ml |
| 48 | Levo Salbutamol Respiratory Solution 0.0625 mg/ml 10 ml |
| 49 | Methyl Prednisolone Inj 40 mg/ml 1 ml |
| 50 | Tab.Predinisolone5mg |
| 51 | Tab.Predinisolone 10 mg |
| 52 | Tab. Predinisolone20mg |
| 53 | Autoclave indicatortape |
| 54 | Surgical Blade no. 15 |
